Clinical Trials
192 trialsEvaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
University of Kentucky
TRIDENT-1
Turning Point Therapeutics, Inc.
Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment
University Hospital, Geneva
Pan Tumor Rollover Study
Bristol-Myers Squibb
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
AbbVie
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
National Institutes of Health Clinical Center (CC)
TAOIST
Hospices Civils de Lyon
ROXI-CAT-I
Regeneron Pharmaceuticals
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
GlaxoSmithKline
CAR-Lille
University Hospital, Lille
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
National Institutes of Health Clinical Center (CC)
Collection of Tissue Samples for Cancer Research
National Institutes of Health Clinical Center (CC)
EVEREST-2
A2 Biotherapeutics Inc.
MOBITEP
Centre Hospitalier Régional d'Orléans
MICROBLADDERK
Centre Hospitalier Universitaire de Nice
A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial
Wake Forest University Health Sciences
Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
Wake Forest University Health Sciences
Comprehensive Care for AYA: Needs Assessment Survey
Wake Forest University Health Sciences
KANDLELIT-014
Merck Sharp & Dohme LLC
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Merck Sharp & Dohme LLC
MK-3475-G21
Merck Sharp & Dohme LLC
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
National Institutes of Health Clinical Center (CC)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
Clinical and Genetic Studies of Li-Fraumeni Syndrome
National Institutes of Health Clinical Center (CC)
Tumor Related Epilepsy
National Institutes of Health Clinical Center (CC)
Sample Collection and Tracking for the Developmental Therapeutics Clinic
National Institutes of Health Clinical Center (CC)
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Bio-lung
University Hospital, Lille
Patient-Centered Assessment of Symptoms and Outcomes
National Institutes of Health Clinical Center (CC)
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
National Institutes of Health Clinical Center (CC)
BACCHUS
University Hospital, Lille
Galleri® in the Medicare Population.
GRAIL, Inc.
MCW I-PREDICT
Medical College of Wisconsin
PIKALO-1
Eli Lilly and Company
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Amgen
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
Virginia Commonwealth University
BEHOLD-1
GlaxoSmithKline
PanTumor-101
GlaxoSmithKline
IMPACT
Medical University of South Carolina
Falcon Real World Evidence Registry
Exact Sciences Corporation
BEHOLD-2
GlaxoSmithKline
A Study of Live Tumor Fragments of Surgical Resections
Mayo Clinic
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
AbbVie
A Study of Herbal Supplements in Cancer Survivors With Constipation
Memorial Sloan Kettering Cancer Center
BRAVO
Hospital Alemão Oswaldo Cruz
RELAX
Wake Forest University Health Sciences
Patient Position Monitoring System for Beam Gated Radiation Therapy of Malignancies of the Chest and Upper Abdomen
Washington University School of Medicine